Power Law company profile

Nxera Pharma UK | Heptares Therapeutics

Biotech & Life Sciences · Great Abington, United Kingdom · Founded 2007 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$100–500M

Latest valuation · 2026

Unlock exact value

Revenue

$50–100M

Latest reported FY

Unlock exact value

Investors

7 investors on Nxera Pharma UK | Heptares Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage

Series A 2 investors entered at this stage

Series B+ 4 investors entered at this stage

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo